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Abstract
Background: The	transition	from	a	tooth	requiring	extraction	to	its	replacement	(with	
a	dental	 implant)	 requires	a	series	of	clinical	decisions	related	to	timing,	approach,	
materials,	cost-	effectiveness	and	the	assessment	of	potential	harm	and	patient	pref-
erence.	 This	 workshop	 focused	 on	 the	 formulation	 of	 evidence-	based	 consensus	
statements	and	clinical	recommendations.
Methods: Four	systematic	reviews	covering	the	areas	of	alveolar	ridge	preservation/
bone	 grafting,	 immediate	 early	 and	 delayed	 implant	 placement	 and	 alveolar	 bone	
augmentation	at	the	time	of	implant	placement	in	a	healed	ridge	formed	the	basis	of	
the	deliberations.	The	level	of	evidence	supporting	each	consensus	statement	and	its	
strength	was	described	using	a	modification	of	the	GRADE	tool.
Results: The	evidence	base	for	each	of	the	relevant	topics	was	assessed	and	sum-
marized	in	23	consensus	statements	and	12	specific	clinical	recommendations.	The	
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1  | INTRODUC TION
The	 WHO	 oral	 health	 databank	 has	 shown	 important	 progress	
in	 tooth	 retention	over	a	20-	year	period	 (Kassebaum	et	al.,	2014).	
Tooth	extraction	due	to	disease	and/or	trauma,	however,	remains	a	
frequent	occurrence	leading	to	the	indication	of	tooth	replacement,	
such	as	an	implant-	supported	fixed	dental	prosthesis.
It	 is	 important	 to	underline	 that,	 in	 the	vast	majority	of	cases,	
dental	extraction	is	indicated	due	to	severe	disease	or	trauma	that	
has	led	to	irreparable	damage	to	the	tooth	and/or	its	supporting	ap-
paratus.	Different	clinical	scenarios	with	varying	extent	and	patterns	
of	residual	alveolar	bone,	therefore,	may	be	encountered.	Hence,	a	
careful	examination	should	be	carried	out	before	and	immediately	
after	tooth	extraction	in	order	to	assess	the	applicability	of	different	
therapeutic	strategies,	which	may	involve	implant	placement.
Noteworthy,	 the	 decision	 to	 extract	 a	 tooth	 is	 intricately	 con-
nected	with	 thought	processes	 related	 to	 its	 replacement,	 the	 as-
sessment	of	the	evidence	pertaining	to	available	treatment	choices	
for	both	 its	 retention	 and	 replacement,	 the	 cost-	benefit	 profile	of	
the	available	options	and,	ultimately,	 individual	preferences	of	 the	
patient	and	the	treating	clinician.
Following	tooth	extraction,	a	series	of	physiological	changes	af-
fecting	the	alveolar	bone	that	surrounds	the	extraction	socket	take	
place	 (Sculean,	 Stavropoulos,	 &	 Bosshardt,	 2019).	 These	 include	
bone	formation	in	the	socket	as	well	as	volumetric	resorption	lead-
ing	to	changes	in	the	dimensions	and	contours	of	the	alveolar	ridge.	
A	previous	meta-	analysis	found	that	average	reductions	of	3.87	mm	
(95%	CI:	−4.059	to	−3.673)	in	the	buccolingual	ridge	thickness	and	a	
vertical	mid-	buccal	resorption	of	1.67	mm	(95%	CI:	−1.910	to	−1.428)	
are	 to	 be	 expected	 following	 unassisted	 socket	 healing	 (van	 der	
Weijden,	Dell'Acqua,	&	Slot,	2009).	Attempts	to	 limit	bone	resorp-
tion,	shorten	the	overall	 treatment	time	and	maximize	therapeutic	
predictability	have	led	to	the	development	of	five	documented	ap-
proaches	that	differ	depending	on	variations	in	the	management	of	
group	emphasized	that	the	evidence	base	mostly	relates	to	single	tooth	extraction/re-
placement;	hence,	external	validity/applicability	to	multiple	extractions	requires	care-
ful	consideration.	The	group	identified	six	considerations	that	should	assist	clinicians	
in	clinical	decision-	making:	presence	of	infection,	inability	to	achieve	primary	stability	
in	the	restoratively	driven	position,	presence	of	a	damaged	alveolus,	periodontal	phe-
notype,	aesthetic	demands	and	systemic	conditions.
Conclusions: A	substantial	and	expanding	evidence	base	 is	available	 to	assist	clini-
cians	with	 clinical	 decision-	making	 related	 to	 the	 transition	 from	a	 tooth	 requiring	
extraction	 to	 its	 replacement	with	 a	 dental	 implant.	More	 high-	quality	 research	 is	
needed	for	the	development	of	evidence-	based	clinical	guidelines.
K E Y W O R D S
alveolar	ridge	preservation,	bone	grafting,	clinical	guidelines,	dental	implant,	evidence-based	
dentistry,	implant	performance,	implant	placement/timing,	implant	survival,	tooth	extraction
Clinical Relevance
Scientific rationale for the study:	Clinical	decisions	on	how	
to	best	transition	from	a	tooth	requiring	extraction	to	 its	
implant	 replacement	 require	 the	 consideration	 of	 a	wide	
range	of	evidence.
Principal findings:	 The	 discussions	 of	 this	workshop	were	
informed	 by	 four	 specifically	 commissioned	 systematic	
reviews.	The	evidence	was	graded,	 and	consensus	 state-
ments	were	 formulated	 along	with	 clinical	 recommenda-
tions.	A	substantial	body	of	evidence	is	available	to	guide	
clinicians	in	making	evidence-	based	decisions.
Practical implications:	 In	 their	 decision-	making	 process,	
clinicians	should	pay	particular	attention	 to	 the	presence	
of	 infection,	 inability	 to	 achieve	 primary	 stability	 of	 the	
implant	in	the	restoratively	driven	position,	presence	of	a	
damaged	 alveolus,	 periodontal	 phenotype,	 aesthetic	 de-
mands	and	systemic	conditions.
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the	extraction	site	and	the	timing	of	implant	placement.	These	ap-
proaches	are	illustrated	in	Figure	1	and	include	the	following:
•	 A	conventional	treatment	protocol	involving	tooth	extraction	and	
unassisted	healing	of	the	extraction	site	for	a	period	of	>16	weeks,	
followed	by	 implant	placement	 in	a	healed	 ridge.	This	approach	
has	been	termed	type	4	implant	placement.
•	 A	 conventional	 protocol	 modified	 by	 performing	 an	 interceptive	
procedure	to	minimize	the	dimensional	changes	that	take	place	after	
tooth	extraction,	followed	by	implant	placement	12–16	weeks	later.	
This	approach	has	been	called	alveolar	ridge	preservation	(ARP),	and	
it	represents	a	modified	type	3	or	type	4	implant	placement	(further	
referred	as	Type	3*	or	Type	4*	based	on	time	of	implant	placement).
•	 An	immediate	implant	placement	protocol,	characterized	by	implant	
placement	at	the	time	of	or	shortly	after	tooth	extraction	(<10	days	
after	extraction),	which	is	known	as	type	1	implant	placement.
•	 An	 early	 implant	 placement	 protocol,	 characterized	 by	 implant	
placement	after	completion	of	the	majority	of	soft	tissue	healing,	
but	before	the	occurrence	of	complete	bone	maturation	and	ridge	
profile	modification	(4–8	weeks	after	tooth	extraction,	type	2	im-
plant	placement)
•	 A	delayed	 implant	placement	protocol,	characterized	by	 implant	
placement	after	completion	of	soft	 tissue	healing,	and	after	 the	
majority	of	the	alveolar	bone	healing	and	profile	and	dimensional	
changes	have	taken	place,	which	usually	occurs	at	12–16	weeks	
following	 tooth	extraction.	This	has	been	 termed	as	 type	3	 im-
plant	placement.
The	different	treatment	modalities	illustrated	in	Figure	1,	which	have	
been	described	in	the	literature	and	in	the	systematic	reviews	used	as	
a	basis	for	the	deliberation	at	the	workshop,	are	reflective	of	a	variable	
degree	of	 scientific	 and	 clinical	 validation	 (Gallucci,	Hamilton,	 Zhou,	
Buser,	&	Chen,	2018).	Accounting	for	different	 levels	of	validation	is	
an	important	component	of	the	background	knowledge	necessary	for	
clinical	decision-	making.
In	clinical	practice,	the	choice	between	the	aforementioned	implant	
placement	modalities	 has	 been	 empirically	 based	 on	 the	 assumption	
that	 the	presence/absence	of	an	 intact	 residual	 ridge	or	socket	walls	
is	 an	 indication	 for	 specific	 approaches.	 Evidence	 from	 comparative	
studies	has,	so	far,	played	relatively	little	role	in	clinical	decision-	making	
processes.	 This	 group	 of	 the	workshop	 focused	 on	 summarizing	 the	
scientific	evidence	in	specific	consensus	statements	and	on	providing	
F IGURE  1 Diagrammatic	representation	of	the	different	options	for	implant	replacement	after	tooth	extraction.	Please	note	the	two	
procedures	that	are	performed	at	the	time	of	tooth	extraction	and	the	other	three	that	are	performed	at	a	later	time.	ARP,	alveolar	ridge	
preservation.	The	figure	illustrates	the	five	different	options,	numbered	1–5,	available	after	tooth	extraction	to	transition	towards	an	implant	
supported	restoration.	Two	interventions,	immediate	implant	placement	and	alveolar	ridge	preservation	(ARP),	are	performed	at	the	time	of	
tooth	extractions.	Three	additional	options	are	available	following	different	degrees	of	healing	after	the	extraction:	early	soft	tissue	healing,	
partial	bone	healing	and	full	bone	healing.	All	options	can	theoretically	be	performed	with	or	without	the	addition	of	bone	regeneration.	
The	figure	also	illustrates	the	four	types	of	implant	placement:	type	1	(immediate,	0–1	week),	type	2	(early,	4–8	weeks),	type	3	(delayed,	
3–4	months)	and	type	4	(standard	placement	in	a	healed	ridge,	>4	months).	The	diagram	introduces	type	3*	and	type	4*	implant	placement:	
this	refers	to	implant	placement	in	a	ridge	that	has	been	preserved	and	the	3*	or	4*	classification	refers	to	the	duration	of	healing	of	the	ARP	
procedure	before	implant	placement.	Please	see	text	for	additional	details
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clinical	 recommendations	 relevant	 to	 these	 therapeutic	 alternatives.	
Table	1	 illustrates	 the	modified	GRADE	criteria	used	 to	describe	 the	
level	of	available	evidence	and	the	strength	of	the	statements/clinical	
recommendations	(Guyatt	et	al.,	2011;	Tonetti	&	Jepsen,	2014).
2  | EFFEC T OF ALVEOL AR RIDGE 
PRESERVATION INTERVENTIONS 
FOLLOWING TOOTH E X TR AC TION: A 
SYSTEMATIC RE VIE W AND META- ANALYSIS
2.1 | Preamble
Tooth	extraction	triggers	a	sequence	of	biologic	events	that	typically	
result	in	the	horizontal	and	vertical	reduction	in	alveolar	ridge	dimen-
sions,	and	subsequent	changes	in	its	profile,	which	may	interfere	with	
further	therapy.	ARP	is	frequently	indicated	to	attenuate	these	physio-
logic	dimensional	changes	(Avila-	Ortiz,	Chambrone,	&	Vignoletti,	2019).
The	aim	of	 this	 systematic	 review	was	 to	critically	 analyse	 the	
available	evidence	on	 the	effect	of	different	modalities	of	ARP	as	
compared	 to	 tooth	 extraction	 alone.	 ARP	 interventions	 were	 de-
fined	as	filling	the	socket	with	a	biomaterial	(Alveolar	ridge	preser-
vation	via	socket	grafting	[ARP-	SG]),	socket	sealing	(SS)	through	the	
sole	application	of	a	barrier	material	(autogenous	or	exogenous)	or	a	
combination	of	both,	either	involving	primary	intention	healing	fol-
lowing	flap	advancement	or	secondary	intention	healing.	Outcomes	
were	organized	 in	 three	main	categories:	clinical,	 radiographic	and	
patient-	reported	outcome	measures	(PROMs).
The	systematic	review	included	25	articles	from	a	total	of	22	RCTs.
Sufficient	data	were	available	to	perform	18	meta-	analyses	com-
paring	five	different	ARP-	SG	treatment	modalities	to	the	control	(un-
assisted	socket	healing).
Potential	limitations	of	this	systematic	review	are	the	low	num-
ber	of	 studies	 included	 in	some	of	 the	subcategory	meta-	analyses	
and	that	none	of	the	RCTs	exhibited	a	low	risk	of	bias,	which	calls	for	
caution	when	interpreting	these	findings.	Due	to	the	high	degree	of	
clinical	heterogeneity	that	exists	between	the	majority	of	trials	 in-
cluded,	the	conduction	of	a	network	meta-	analysis	was	not	justified.
2.2 | External validity of the findings
The	 statements	 on	ARP-	SG	 in	 this	 consensus	 report	 are	 primarily	
applicable	to	adults	who	require	a	single	extraction	in	tooth-	bound	
sites	 that	exhibit	 substantial	 socket	wall	 integrity	after	extraction,	
regardless	 of	 smoking	 status.	 Reasons	 for	 extraction	may	 include	
catastrophic	 tooth	 fractures,	extensive	caries	and	endodontic	 fail-
ure.	A	word	of	caution	 is	needed	with	 regard	 to	 tooth	 loss	due	to	
severe	periodontitis,	as	very	limited	residual	bony	walls	may	be	avail-
able	for	worthwhile	ridge	preservation.
2.3 | Consensus statements
2.3.1 | What is the effect of alveolar ridge 
preservation via socket grafting on ridge dimensions?
Alveolar	 ridge	 preservation	 via	 socket	 grafting	 attenuates	 the	
physiological	bone	dimensional	changes	that	typically	follow	tooth	
extraction.
(Evidence	Level	1:	systematic	review	of	RCTs,	18	RCTs	and	612	
subjects)—(Strength	of	statement:	high).
Alveolar	 ridge	 preservation	 via	 socket	 grafting	 may	 prevent	
1.5–2.4	mm	of	horizontal,	1–2.5	mm	of	vertical	mid-	buccal	and	0.8–
1.5	mm	of	mid-	lingual	vertical	bone	resorption	as	compared	to	tooth	
extraction	alone.
(Evidence	Level	1:	meta-	analysis	of	systematic	 review	of	RCTs,	
14	RCTs	and	676	subjects).	(Strength	of	statement:	high).
2.3.2 | How do different alveolar ridge preservation 
modalities compare in terms of their effect on ridge 
dimensions?
In	spite	of	the	presence	of	multiple	studies	comparing	a	variety	of	
bone	grafts	 and	SS	 approaches,	 it	was	not	 possible	 to	 identify	 an	
ARP	approach	associated	with	superior	outcomes.	This	finding	does	
not	imply	that	any	bone	grafting	and/or	SS	material	unfailingly	brings	
a	therapeutic	benefit,	as	only	few	materials	are	appropriately	docu-
mented.	The	reader	is	referred	to	the	original	systematic	review	for	
a	detailed	compilation	of	the	evidence	for	individual	ARP	treatment	
modalities	and	grafting	materials.
(Evidence	 Level	 2:	 systematic	 review	 without	 network	 meta-	
analysis,	22	RCTs	and	730	subjects)—(Strength	of	statement:	moderate).
2.3.3 | What is the impact of buccal bone thickness 
on dimensional changes?
Sites	presenting	a	thick	buccal	bone	(e.g.	>1.0–1.5	mm)	exhibit	less	
alveolar	ridge	dimensional	changes	after	tooth	extraction.	It	has	also	
TABLE  1 Specific	modified	GRADE	criteria	used	to	describe	the	
level	of	evidence	and	the	strength	of	a	clinical	statement
Level of evidence Definition criteria
Level 1 Systematic	review	with	meta-	analysis
Level 2 Systematic	review	without	meta-	analysis,	
single	multicenter	RCT,	multiple	RCTs
Level 3 Single	RCT,	RCTs	designed	for	different	
reason
Level 4 Case	series,	CCTs
Level 5 Expert	opinion
Strength of 
statement Definition criteria
High High	level	of	confidence:	low	risk	of	bias,	
adequate	number	of	subjects	and	trials,	
negligible	heterogeneity
Moderate Good	confidence,	some	risk	of	bias,	heteroge-
neity,	adequate	number	of	subjects	and	trials
Low Not	confident,	high	risk	of	bias,	uncertainty
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been	observed	that	the	application	of	ARP-	SG	is	more	beneficial	in	
sites	exhibiting	thin	buccal	bone.
(Evidence	Level	2:	systematic	review	without	meta-	analysis,	five	
RCTs	and	212	subjects).	(Strength	of	statement:	moderate).
2.3.4 | What is the effect of alveolar ridge 
preservation—Socket Grafting on the feasibility of 
implant placement without a second augmentation?
The	feasibility	of	implant	placement	without	simultaneous	ancillary	
grafting	is	higher	in	sites	that	have	received	ARP-	SG,	but	additional	
bone	 augmentation	 at	 the	 time	 of	 implant	 placement	 may	 be	 re-
quired	after	both	ARP-	SG	and	unassisted	socket	healing.
(Evidence	Level	2:	systematic	review	of	RCTs	without	meta-	analysis,	
five	RCTs	and	214	subjects)	(Strength	of	statement:	moderate).
2.3.5 | What is the performance of implants 
inserted at sites with alveolar ridge preservation?
Sites	 that	 received	ARP-	SG	 exhibit	 no	 differences	 compared	with	
sites	that	underwent	unassisted	socket	healing	in	terms	of	 implant	
loss	and	implant	success	after	a	minimum	of	12	months	of	functional	
loading	with	the	final	prosthesis.
(Evidence	Level	2:	systematic	review	of	RCTs	without	meta-	analysis,	
three	RCTs	and	95	subjects).	(Strength	of	statement:	moderate).
2.4 | Clinical recommendations
2.4.1 | When should clinicians consider ARP 
following tooth extraction?
Clinicians	should	consider	ARP	in	clinical	scenarios	in	which	minimiz-
ing	alveolar	ridge	dimensional	changes	is	critical,	such	as
•	 Extraction	sites	in	areas	of	aesthetic	priority,	both	when	an	implant-sup-
ported	and	a	tooth-retained	(e.g.	pontic	site)	restoration	is	planned.
•	 Extraction	sites	on	which	major	ridge	reduction	is	expected	and	
may	jeopardize	implant	placement,	such	as
o	 Sites	 presenting	 a	 thin	 and/or	 substantially	 damaged	 buccal	
bone	plate.
o	 Posterior	sites	exhibiting	limited	ridge	height	post-extraction,	
which	may	lead	to	implant	proximity	to	the	maxillary	sinus	or	
nerve	structures.
•	 In	situations	requiring	that	implant	placement	is	significantly	delayed	
after	tooth	extraction,	such	as,	due	to	the	young	age	of	the	patient.
2.4.2 | Which ARP treatment modality is most 
effective?
The	application	of	a	bone	grafting	material	to	fill	the	extraction	socket	
is	strongly	recommended	when	ARP	is	indicated.	Clinicians	should	also	
consider	sealing	the	socket	orifice	using	an	autogenous	or	exogenous	
barrier	material	with	 the	purpose	of	protecting	 the	underlying	bone	
compartment	and/or	assist	soft	tissue	healing.	Socket	sealing	can	be	
achieved	either	with	or	without	primary	soft	tissue	closure.
2.4.3 | How much healing time following 
ARP therapy is recommended prior to implant 
placement?
A	minimum	healing	time	that	allows	for	sufficient	bone	formation,	
typically	3–4	months,	 is	 recommended.	An	extended	healing	 time	
may	be	required	on	the	basis	of	the	phenotypic	characteristics	of	the	
extraction	site,	the	properties	of	the	biomaterial(s)	used	and	patient-	
specific	systemic	factors.
2.5 | Recommendations for future research
There	 is	 a	 need	 to	 conduct	well-	designed	 RCTs	 involving	multiple	
arms	that	would	allow	for	direct	comparisons	of	different	ARP	mo-
dalities	 of	 therapy,	 including	 socket	 grafting	 and	 sealing	materials,	
in	different	clinical	scenarios	(e.g.	single-	vs	multi-	rooted	sites;	dam-
aged	vs	 intact	 sockets).	 Relevant	 endpoints	 of	 interest	 that	 go	be-
yond	conventional	linear	clinical	and	radiographic	assessments,	such	
as	 bone	 and	 soft	 tissue	 volumetric	 dimensional	 changes,	 implant-	
related	 outcomes	 and	 PROMs,	 should	 be	 considered.	Additionally,	
these	 studies	 should	 incorporate	 properly	 described,	 reproducible	
methods	 for	 assessment	 of	 outcomes	 of	 therapy	 that	would	 allow	
for	external	validation,	cost-	benefit	analyses	and	the	performance	of	
robust	meta-	analyses.
Future	research	should	elucidate	the	influence	of	local	and	sys-
temic	patient-	specific	factors	on	the	outcomes	of	ARP	therapy	(e.g.	
presence	 of	 concomitant	 pathology,	 soft	 tissue	 thickness,	 kerati-
nized	mucosa	width,	 smoking,	 history	 of	 periodontitis	 and	uncon-
trolled	 systemic	 conditions	 that	may	play	 a	 role	 in	 intra-	oral	 bone	
and	soft	tissue	healing).
3 | THE EFFECTIVENESS OF IMMEDIATE 
IMPLANT PLACEMENT FOR SINGLE TOOTH 
REPLACEMENT COMPARED TO DELAYED IMPLANT 
PLACEMENT: A SYSTEMATIC REVIEW AND META- 
ANALYSIS
3.1 | Preamble
The	main	goal	and	 the	primary	outcome	of	 this	 systematic	 review	
were	to	compare	immediate	implant	placement	for	single	tooth	re-
placement	to	delayed	implant	placement	in	terms	of	implant	survival	
(Cosyn	et	al.,	2019).
Secondary	outcomes	included	the	following:
•	 Need	 for	 additional	bone	augmentation	at	 the	buccal	 aspect	of	
the	implant
•	 Wound-healing	complications
•	 Marginal	bone	loss
•	 Probing	depth	and	bleeding	on	probing
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• Papillary recession
•	 Pink	aesthetic	score
•	 Patient-reported	outcome	measures
•	 Long-term	complications.
The	present	systematic	review	includes	eight	investigations,	compris-
ing	three	RCTs	and	five	CCTs.	The	study	material	included	512	patients	
(517	implants)	with	a	follow-	up	ranging	from	12	to	96	months.
Sufficient	data	were	available	to	perform	meta-	analyses	of	the	
primary	outcome	and	a	limited	number	of	secondary	outcomes.
3.2 | External validity of the findings
The	statements	in	this	consensus	report	are	primarily	applicable	to	
adults	who	require	extraction	of	one	single-	rooted	tooth	with	sub-
stantial	socket	wall	integrity	at	the	time	of	extraction	in	tooth-	bound	
areas.	 The	majority	 of	 the	 studies	 inclusion	 and	 exclusion	 criteria	
limited	cases	to	sites	without	acute	infection	and	with	possibility	to	
achieve	primary	 stability	of	 the	 immediately	placed	 implant	 in	 the	
correct,	prosthetically	driven,	position.
3.3 | Consensus statements
3.3.1 | What clinical conditions have been included 
in studies comparing immediate and delayed implant 
placement?
Studies	 comparing	 immediate	 and	 delayed	 implant	 placement	
have	used	different	inclusion	and	exclusion	criteria,	and	these	are	
important	 for	 understanding	 heterogeneity	 of	 results.	 A	 critical	
component	 is	whether	 the	buccal	bone	plate	was	essentially	 in-
tact	or	 not.	Diverging	 results	were	observed	 in	one	multicenter	
RCT	that	included	extraction	sockets	with	up	to	50%	loss	of	the	
buccal	bone	plate	and	the	other	RCT	that	included	essentially	in-
tact	 sockets.	 These	 observations	may	 indicate	 that	 the	 level	 of	
buccal	 bone	 loss	 is	 a	major	 prognostic	 factor	 for	 immediate	 im-
plant	placement.
(Evidence	Level	4:	Two	RCTs	designed	for	different	purpose	and	
showing	heterogeneous	results).	(Strength	of	the	statement:	low	due	
to	limited	and	indirect	evidence	and	heterogeneity).
3.3.2 | How do immediate and delayed implant 
placement compare in terms of implant loss?
Immediate	 implant	 placement	 results	 in	 greater	 early	 implant	 loss	
compared	with	delayed	implant	placement	(survival	rate	of	94.9%	vs	
98.9%;	RR	0.96,	95%	CI	[0.93;	0.99],	p = 0.02).
(Evidence	Level	1:	systematic	review	with	meta-	analysis	compris-
ing	three	RCTs—135	subjects	with	136	immediate	implants	and	131	
subjects	 with	 135	 delayed	 implants—and	 five	 CCTs—120	 subjects	
with	120	immediate	implants	and	126	subjects	with	126	delayed	im-
plants)—(Strength	of	the	statement:	moderate	due	to	heterogeneity	
and	risk	of	bias).
3.3.3 | How do immediate and delayed implant 
placement compare in terms of marginal bone loss?
Considering	 the	 baseline	 after	 loading	 (definitive	 crown	 installation),	
there	are	only	two	RCTs	(110	patients	with	111	immediate	implants	and	
106	patients	with	110	delayed	implants)	measuring	marginal	bone	loss.
In	both	RCTs,	bone	augmentation	was	performed.	 In	one	RCT,	
immediate	implants	were	placed	in	case	of	dehiscence	up	to	50%	of	
the	buccal	bone	wall	resulting	in	1.2	mm	higher	marginal	bone	loss	
for	immediate	implant	placement.	However,	in	the	other	RCT	where	
an	intact	buccal	bone	wall	was	an	inclusion	criterion,	no	significant	
difference	in	marginal	bone	loss	was	observed.
(Evidence	Level	2:	One	multicenter	RCT	and	one	RCT)—(Strength	
of	the	statement:	low	due	to	heterogeneity).
3.3.4 | How do immediate and delayed implant 
placement compare in terms of probing depth?
Probing	pocket	depths	were	reported	in	one	multicenter	RCT.	Probing	
pocket	depths	were	greater	at	immediate	implant	compared	with	de-
layed	placement	(mean	difference	0.8	mm.	95%	CI:	0.4–1.2	mm)	in	this	
particular	multicenter	RCT	with	non-	intact	buccal	bone	wall.
(Evidence	Level	2:	One	multicenter	RCT,	124	patients)—(Strength	
of	the	statement:	low	due	to	single	multicenter	RCT).
3.3.5 | How do immediate and delayed implant 
placement compare in terms of pink aesthetic  
score?
One	multicenter	RCT	showed	a	trend	towards	lower	pink	aesthetic	
scores	 for	 immediate	 implant	 placement	 in	 cases	 with	 non-	intact	
buccal bone wall.
(Evidence	 Level	 2:	 One	 multicenter	 RCT	 and	 124	 patients)—
(Strength	of	the	statement:	low	due	to	single	multicenter	RCT).
3.4 | Clinical recommendations
3.4.1 | Can immediate implant placement be 
recommended for single tooth replacement?
Clinicians	considering	 immediate	 implant	placement	should	be	aware	
that	it	carries	an	additional	risk	of	early	implant	loss	(4%	excess	implant	
loss).	 Furthermore,	 at	 sites	 with	 non-	intact	 alveolar	 sockets,	 inferior	
clinical,	 radiographic	 and	 patient-	reported	 outcomes	 have	 been	 ob-
served.	No	high-	level	comparative	data	are	available	for	intact	sockets.
3.4.2 | When should immediate implant placement 
be avoided?
Immediate	implant	placement	should	be	avoided	at
•	 Extraction	sites	with	severely	damaged	sockets	(more	than	50%	
loss of one or more walls).
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•	 Extraction	sites	in	which	achievement	of	primary	stability	requires	
positioning	of	the	implant	in	a	prosthetically	incorrect	position.
•	 Extraction	 sites	 in	 which	 achievement	 of	 primary	 stability	 re-
quires	selecting	an	improper	implant	diameter.
3.4.3 | Should grafting be considered an integral 
component of immediate implant placement?
Grafting	at	immediate	implant	placement	is	an	integral	component	of	
the	procedure	in	the	majority	of	cases.
3.4.4 | Which are the clinical indications of 
immediate implant placement?
Immediate	 implant	 placement	may	 bring	 tangible	 patient	 benefits	
related	to	shorter	treatment	time	and	cost-	efficiency.	At	this	stage,	
indications	should	be	limited	to	sites	and	patients	that	are	perceived	
to	be	at	 low	 risk:	non-	aesthetic	areas,	 intact	alveoli,	 thick	and	 flat	
periodontal	phenotype.
3.5 | Recommendations for future research
There	is	a	need	for	additional	high-	quality	RCTs	comparing	immediate	
implant	placement	to	delayed	implant	placement	with	CBCT	analyses	
at	 different	 time	 points.	 Data	 should	 report	 on	 midfacial	 recession	
with	the	situation	prior	to	tooth	extraction	as	baseline.	In	these	stud-
ies,	the	need	for	hard	and	soft	tissue	grafting	should	also	be	evaluated.
There	is	a	need	for	PROMs,	as	these	have	been	underreported	in	
research	so	far.	These	should	include	morbidity	and	patient	preference.	
There	is	a	need	for	cost	and	efficiency	analyses	on	both	protocols.
4  | EFFEC TIVENESS AND PERFORMANCE 
OF E ARLY IMPL ANT PL ACEMENT FOR 
SINGLE TOOTH SITES OF ANTERIOR 
ARE A S: A SYSTEMATIC RE VIE W
4.1 | Preamble
Early	 implant	 placement	 has	 been	 advocated	 to	 address	 several	
shortcomings	 of	 conventional	 and	 immediate	 timing	 of	 insertion.	
These	include	(a)	minimizing	the	potential	negative	effects	of	wound	
contamination	 from	 residual	 infection	 due	 to	 the	 cause	 of	 tooth	
loss;	 (b)	 limiting	 the	potential	 negative	effects	 resulting	 from	hard	
and	 soft	 tissue	 healing	 after	 tooth	 extraction;	 and	 (c)	 decreasing	
treatment	 time	 with	 the	 potential	 to	 improve	 patient	 satisfaction	
(Graziani	et	al.,	2019).
The	systematic	review	identified	data	from	six	studies	from	five	
research	groups	reporting	on	a	total	of	140	implants	in	140	subjects	
(107	for	type	II	and	33	for	type	III).	Paucity	of	data,	lack	of	compara-
tive	studies	of	high-	quality	and	study	heterogeneity	prevented	exe-
cuting	of	meta-	analyses.	The	group	expresses	major	concerns	on	the	
scientific	methodology	and	publication	strategies	observed	in	some	
of	the	included	manuscripts.
While	both	 types	of	early	 implant	placement	seemed	to	perform	
well	 in	 these	 studies,	 significant	 issues	 in	 terms	of	 study	design	 and	
reporting,	the	pilot/proof	of	principle	sample	sizes	and	the	absence	of	
valid	comparisons	with	other	implant	placement	timing	and	approaches	
limit	both	the	internal	validity	and	the	external	validity	of	the	results.
4.2 | External validity of the findings
The	small	number	of	documented	and	highly	selected	patients	(140	sub-
jects	treated	by	five	experienced	surgeons)	and	the	concerns	with	the	
design	of	the	only	RCT	severely	limit	the	generalizability	of	the	results.
4.3 | Consensus statements
4.3.1 | How do early and delayed implant placement 
compare in terms of implant loss?
There	are	no	valid	comparative	data	 that	have	tested	early	and	de-
layed	 implant	placement.	Reported	clinical	performance	shows	high	
levels	of	implant	survival	in	small	studies	with	up	to	10	years	follow-	up.
(Evidence	 Level	 4:	 One	 RCT	 at	 high	 risk	 of	 bias	 and	 probably	
invalid,	one	CCT	and	four	retrospective	or	prospective	case	series,	
140	 subjects	with	 140	 implants)—(Strength	 of	 the	 statement:	 low	
due	to	small	sample,	heterogeneity	and	risk	of	bias).
4.3.2 | How do immediate and early implant 
placement compare in terms of implant loss?
There	are	no	valid	comparative	data	that	have	tested	immediate	and	
early	implant	placement.	Reported	clinical	performance	shows	high	
levels	of	implant	survival	for	both	approaches.
(Evidence	Level	5:	expert	opinion)—(Strength	of	the	statement:	
low	due	to	expert	opinion	in	the	absence	of	direct	evidence).
4.3.3 | What clinical conditions have been included 
in studies reporting on the performance of early 
implant placement?
Causes	 of	 tooth	 extraction/loss	were	 generally	 not	 reported,	 and	
neither	were	the	conditions	of	the	residual	bony	walls	of	the	alveo-
lus.	The	assumption	that	the	main	indication	for	early	implant	place-
ment	 is	 extraction	 at	 sites	with	 compromised	 alveoli	 needs	 to	 be	
substantiated	with	additional	research.
(Evidence	Level	5:	expert	opinion)—(Strength	of	the	statement:	
low	due	to	expert	opinion	in	the	absence	of	direct	evidence).
4.3.4 | What is the performance of early 
implant placement in terms of peri- implant health 
parameters and aesthetics?
Few	case	series	reporting	on	a	limited	number	of	patients	have	de-
scribed	 good	 and	 stable	 outcomes	with	 type	 2	 and	 type	 3	 place-
ments.	 Their	 strength	 is	 the	 long-	term	 follow-	up.	 It	 is,	 however,	
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unclear	how	these	results	compare	with	those	obtainable	with	other	
types	of	placement	and	what	is	their	external	applicability.
(Evidence	Level	4:	case	series	at	different	risk	of	bias)—(Strength	
of	statement:	low	due	to	the	absence	of	RCTs	and	limited	number	of	
documented	cases).
4.4 | Clinical recommendations
4.4.1 | Is there evidence to recommend type 2 or 
type 3 implant placement in the anterior region?
Clinicians	should	be	aware	that	the	evidence	on	type	2	and	type	3	implant	
placement	is	based	on	a	restricted	number	of	experienced	clinicians	(five	
surgeons)	who	have	treated	and	followed	a	 limited	number	of	patients	
(N	=	140	implants/patients	followed	for	at	least	1	year,	see	also	Gallucci	
et	al.,	2018).	The	limited	available	evidence	shows	good	performance	in	
the	hands	of	few	experienced	clinicians	and	highly	selected	patients.	It	is,	
however,	unclear	if	such	data	can	be	generalized	and	how	they	compare	
with	those	following	immediate	or	delayed	implant	placement.
4.5 | Recommendations for future research
Randomized	clinical	 trials	comparing	different	 types	of	 implant	 in-
sertion	are	strongly	advocated.
These	trials	should	be	designed	taking	into	account	not	only	the	
survival	 rate	but	also	a	broad	array	of	clinically	relevant	outcomes	
ranging	from	aesthetic	outcomes,	dimensional	hard	and	soft	tissue	
changes,	and	patient-	reported	outcomes.
Trials	should	be	carefully	designed	to	evaluate	the	impact	of	sig-
nificant	 confounders	 such	 as	 causes	 of	 tooth	 extraction/loss,	 the	
conditions	 of	 the	 alveolus,	 concomitant	 bone	 regenerative	 proce-
dures	and	type	of	restorations.
5  | EFFIC ACY OF L ATER AL BONE 
AUGMENTATION PERFORMED 
SIMULTANEOUSLY WITH DENTAL IMPL ANT 
PL ACEMENT: A SYSTEMATIC RE VIE W AND 
META- ANALYSIS
5.1 | Preamble
The	concept	of	placing	dental	 implants	 in	a	prosthetically	driven	
position	often	results	in	ridge	deficiencies	and	the	need	for	an	ad-
ditional	bone	augmentation	procedure	simultaneously	with	dental	
implant	 placement.	 Guided	 bone	 regeneration	 applying	 various	
biomaterials	 and	 barrier	membranes	 is	 indicated	 in	 such	 clinical	
situations.	Clinically,	it	is	difficult	to	decide	on	a	specific	interven-
tion	given	the	vast	variety	of	biomaterials	and	membranes	avail-
able	(Thoma,	Bienz,	Figuero,	Jung,	&	Sanz-	Martin,	2019).
Therefore,	the	present	systematic	review	analysed	the	scientific	
evidence	regarding	the	efficacy	of	lateral	bone	augmentation	proce-
dures	in	terms	of	defect	resolution	in	cases	of	horizontal	ridge	defi-
ciencies	after	implant	placement.
The	mean	defect	height	resolution	at	re-	entry	(in	mm	and/or	%)	
was	considered	as	the	primary	outcome.	Moreover,	the	influence	of	
the	type	of	membrane,	the	absence	of	treatment,	the	addition	of	a	
grafting	material	and	the	addition	of	a	membrane	on	defect	height	
resolution	were	evaluated.
Secondary	outcomes	included	the	following:
•	 Necessity	for	re-grafting
•	 Membrane	exposure
•	 Implant	survival
•	 Clinical,	 radiographic	 and	 volumetric	 outcomes	 of	 follow-up	
studies.
The	 systematic	 review	 includes	 28	 publications	 designed	 as	 RCTs	
(n	=	16),	CCTs	(n	=	4)	or	follow-	up	studies	with	an	RCT	design	(n = 7) 
or	a	CCT	design	(n	=	1).	The	20	short-	term	studies	reported	on	819	
patients	 (1,070	 implants)	 with	 a	 follow-	up	 range	 of	 4–18	months.	
The	eight	follow-	up	studies	reported	on	174	patients	(242	implants)	
with	an	observation	period	that	had	a	range:	36–150	months.	In	all	
included	studies,	 titanium	dental	 implants	with	either	a	smooth	or	
a	moderately	rough	surfaced	were	used.	Defect	configurations	and	
dimensions	present	at	implant	sites	vary	intra-	and	inter-	individually.	
The	selected	literature	did	not	provide	sufficient	information	to	de-
termine	these	specific	confounding	factors	related	to	the	efficacy	of	 
the	procedure.
Meta-	analyses	 were	 performed	 for	 the	 primary	 outcome	 (de-
fect	 height	 resolution)	 and	 whenever	 possible	 for	 secondary	 
outcomes.
5.2 | External validity of the findings
The	 high	 number	 of	 included	 and,	 in	 general,	 well-	designed	 RCTs	
with	a	large	number	of	treated	patients	supports	the	use	of	guided	
bone	 regenerative	procedures	 to	 reconstruct	bone	at	dehiscence-	
type	 defects	 following	 implant	 placement.	 Generalizability	 is	 to	
some	extent	 limited	by	a	 large	heterogeneity	 in	terms	of	materials	
used	and	the	fact	that	no	superiority	of	any	material	(combination)	
could	be	shown.	Clinicians	should	therefore	be	careful	when	choos-
ing	 a	 specific	 bone	 substitute	 and	 barrier	membrane	 combination	
and	check	for	documentation.	It	is	also	important	to	underline	that	
this	 procedure	 has	 been	 generally	 documented	 for	 buccal	 dehis-
cences	up	to	8	mm	in	height.
5.3 | Consensus statements
5.3.1 | What is the percentage of defect height 
resolution after bone augmentation procedures to 
cover exposed implant threads?
Defect	height	resolution	at	re-	entry	ranged	from	56.4%	to	97.1%	at	
4–6	months.
(Evidence	Level	2:	systematic	review	without	meta-	analysis	of	20	
publications	 [16	RCT's	 and	 four	CCTs],	 of	which	nine	had	high,	 five	
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low	and	six	unclear	risk	of	bias	reporting	on	819	subjects	with	1,070	
implants)—(Strength	of	statement:	moderate	due	to	risk	of	bias).
5.3.2 | Is there a benefit to perform a bone 
augmentation procedure to cover exposed implant 
threads following implant placement?
One	 RCT	 demonstrated	 a	 significantly	 more	 favourable	 defect	
height	resolution	for	sites	with	GBR	compared	to	no	treatment.
(Evidence	Level	3:	One	RCT,	22	subjects	and	28	implants	with	an	
unclear	risk	of	bias)—(Strength	of	statement:	low	due	to	small	evidence	
base).
5.3.3 | What is the most effective intervention to 
obtain defect resolution?
All	 barrier	membranes	 and	 bone	 substitute	material	 combinations	
tested	obtained	varying	degrees	of	defect	resolution.
(Evidence	Level	1:	systematic	review	with	meta-	analysis	includ-
ing	11	RCTs,	366	subjects	and	464	implants)—(Strength	of	the	state-
ment:	moderate,	five	RCTs	were	considered	as	low,	three	at	unclear	
and	three	at	high	risk	of	bias).
5.3.4 | Is there a benefit of covering a biomaterial 
with a barrier membrane?
Bone	augmentation	was	significantly	more	 favourable	when	a	bio-
material	was	covered	with	a	membrane	compared	to	a	biomaterial	
alone.
(Evidence	 Level	 1:	 systematic	 review	with	 a	meta-	analysis,	 in-
cluding	 two	RCTs,	 48	 subjects	 and	 52	 implants)—(Strength	 of	 the	
statement:	moderate	due	to	unclear	risk	of	bias).
5.3.5 | Is there a benefit supporting a barrier 
membrane with a biomaterial?
Defect	height	reduction	was	significantly	more	favourable	when	a	bio-
material	supported	a	membrane	compared	to	a	membrane	alone.
(Evidence	 Level	 4:	 One	 CCT,	 19	 subjects	 and	 30	 implants)—
(Strength	 of	 the	 statement:	 low	 (single	 CCT	 at	 high	 risk	 of	 
bias)).
5.3.6 | How frequently bone augmentation 
procedures yield to a 100% defect resolution and 
what is the necessity to re- augment?
The	percentage	of	sites	with	a	100%	defect	resolution	was	reported	
in	one	CCT	only	and	amounted	to	76.7%.
The	 necessity	 to	 re-	augment	 was	 inconsistently	 reported.	 No	
implant	site	needed	re-	augmentation	in	three	RCTs,	whereas	in	two	
studies,	patients	in	need	of	re-	augmentation	were	excluded.
(Evidence	Level	2:	systematic	review	without	meta-	analysis,	five	
RCTs,	 one	 CCT,	 165	 subjects	 and	 199	 implants)—(Strength	 of	 the	
statement:	moderate	since	three	studies	were	considered	as	low	and	
one	as	unclear	risk	of	bias.	The	remaining	two	studies	were	consid-
ered	to	have	a	high	risk	of	bias).
5.3.7 | What is the most common complication?
The	most	 common	 complication	 is	 unintentional	membrane	 expo-
sure	with	a	mean	rate	of	22.7%	(range:	16.8%–39.4%).
(Evidence	Level	2:	systematic	review	without	meta-	analysis	of	16	
RCT's,	four	CCTs,	820	subjects	and	1069	implants)—(Strength	of	the	
statement:	moderate).
Meta-	analyses	did	not	demonstrate	 any	 significant	differences	
between	 different	 biomaterials	 and	 barrier	membranes	 as	well	 as	
their	respective	combinations.
(Evidence	 Level	 2:	 systematic	 review	 without	 meta-	analysis	
including	 12	 RCT's,	 one	 CCT,	 502	 subjects	 and	 768	 implants)—
(Strength	of	 the	statement:	moderate	since	five	studies	were	con-
sidered	as	 low	and	four	as	unclear	risk	of	bias.	The	remaining	four	
studies	were	considered	to	have	a	high	risk	of	bias).
5.3.8 | What are the mid- and long- term 
outcomes of implants following bone augmentation at 
dehiscence and fenestration type defects?
The	implant	survival	rate	was	not	affected	by	the	type	of	treat-
ment	(membrane,	biomaterial,	sites	with	exposed	implant	threads)	
and	amounted	to	95.0%	(298	 implants;	142	patients)	with	a	fol-
low-	up	range	between	36	and	96	months.	The	range	of	biologi-
cal	 complications	 was	 0%–75%	 and	 the	 rate	 of	 peri-	implantitis	
12.8%.
(Evidence	 Level	 2:	 systematic	 review	 without	 meta-	analyses,	
including	 seven	RCTs,	 one	CCT,	 142	 subjects	 and	 298	 implants)—
(Strength	of	the	statement:	moderate	since	one	study	was	consid-
ered	 as	 low	 and	 four	 as	 unclear	 risk	 of	 bias.	 The	 remaining	 three	
studies	were	considered	to	have	a	high	risk	of	bias.)
5.4 | Clinical recommendations
5.4.1 | Is there a need to perform a bone 
augmentation procedure to cover exposed implant 
threads following implant placement?
The	 clinician	 should	 consider	 the	 use	 of	 a	 bone	 augmentation	
procedure	 to	 cover	 exposed	 implant	 threads	 after	 implant	 place-
ment.	 Such	 a	 procedure	 renders	 a	 favourable	 defect	 height	 
resolution.
5.4.2 | When should a clinician apply a bone 
augmentation procedure to cover exposed implant 
threads following implant placement?
The	 clinician	 should	 consider	 a	 bone	 augmentation	 procedure	 to	
cover	exposed	implant	threads	at	different	peri-	implant	defect	con-
figurations	(documented	up	to	a	defect	height	of	8	mm).
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A	staged	bone	augmentation	procedure	might	be	considered	 if	
the	implant	cannot	be	placed	in	a	prosthetically	driven	position,	no	
primary	stability	can	be	obtained	or	in	the	presence	of	an	unfavour-
able	defect	configuration.
5.4.3 | Which intervention is recommended to treat 
peri- implant bone defects?
All	 barrier	 membranes	 and	 bone	 substitute	 material	 combinations	
tested	obtained	varying	 degrees	 of	 defect	 resolution	 (refer	 to	 SR).	
The	 clinician	 should	 combine	 a	 barrier	membrane	with	 a	 biomate-
rial.	Only	few	membranes	and	biomaterials	are	well	documented,	and	
clinicians	 should	 be	 aware	 of	 the	 documentation	 before	making	 a	
choice.
5.4.4 | What complications should clinicians be 
aware of following bone augmentation procedures at 
peri- implant defects?
Clinicians	should	be	aware	of	membrane	exposure	as	the	most	com-
mon	complication.	The	occurrence	of	such	an	adverse	event	results	
in	a	less	favourable	defect	height	resolution.
5.5 | Recommendations for future research
Further	investigations	should	consider	the	following:
•	 The	impact	of	bone	augmentation	at	dehiscence	or	fenestration	
defects	around	dental	implants	on	long-term	peri-implant	health
•	 Evaluating	the	need	for	bone	augmentation	at	dehiscence	or	fen-
estration	defects	around	dental	implants
•	 Evaluating	 the	 threshold	 and	 the	 influence	 of	 defect	 dimen-
sions	 and	 configurations	 on	 clinical,	 biological	 and	 radiographic	
outcomes
•	 Reporting	on	the	success	of	the	treatment	(100%	defect	resolu-
tion)	 and	 on	 the	 impact	 of	 incomplete	 bone	 augmentation	 (e.g.	
<100%	defect	resolution	and	complications)	on	the	efficacy	of	the	
intervention	and	on	clinical,	biological	and	radiographic	outcomes
•	 Reporting	on	the	effect	of	bone	augmentation	procedures	on	the	
hard	and	soft	tissue	contour,	on	the	level	of	the	mucosal	margin	
and	on	aesthetic	outcomes
•	 Including	study	patients	in	mid-	to	long-term	follow-up	examina-
tions	with	standardized	ways	of	reporting	clinical,	biological	and	
radiographic	outcomes	as	well	as	PROMs.
In	general,	for	the	planning	of	future	studies	related	to	bone	augmen-
tation	procedures,	 it	 is	 recommended	to	report	on	specific	 inclusion	
criteria	(e.g.	ridge	dimensions	and	configuration	prior	to	implant	place-
ment;	three-	dimensional	defect	configuration	after	implant	placement;	
and	 extent	 of	 bone	 augmentation),	 surgical	 protocols	 (e.g.	 bone-	 or	
prosthetically	 driven	 implant	 placement),	 early	 (e.g.	 wound	 dehis-
cences	and	barrier	membrane	exposures)	and	late	(e.g.	mucositis	and	
peri-	implantitis)	complications.
6  | OVER ALL CONSENSUS AND 
RECOMMENDATIONS
6.1 | Clinical recommendations
6.1.1 | What is the best approach for transitioning 
from a failing tooth to a successful implant- supported 
tooth replacement prosthesis?
Based	on	strong	pre-	clinical	evidence	(Haugen,	Lyngstadaas,	Rossi,	
&	 Perale,	 2019;	 Donos,	 Dereka,	 &	 Calciolari,	 2019;	 Omar,	 Elgali,	
Dahlin,	 &	 Thomsen,	 2019),	 five	 different	 approaches	 that	 have	
been	 documented	 to	 a	 different	 degree	 in	 clinical	 studies	 are	 il-
lustrated	in	Figure	1.	The	evidence	pertains	mostly	to	single	tooth	
replacement,	 and	 thus,	 extrapolation	 to	 other	 scenarios	may	 not	
apply.	Paucity	of	valid	comparative	studies	does	not	allow	for	the	
construction	 of	 an	 evidence-	based	 decision-	making	 algorithm	 to	
select	a	specific	approach	that	can	be	considered	superior	in	indi-
vidual clinical scenarios.
In	the	absence	of	solid	evidence,	clinicians	have	historically	fol-
lowed	an	empiric	approach	that	has	been	supported	by	indirect	pre-	
clinical	and	clinical	evidence,	mostly	case	series,	to	validate	specific	
protocols.	This	process	involves	the	consideration	of	several	critical	
factors,	such	as	the	presence	of	local	acute	infection	(purulence),	the	
local	anatomy	in	function	of	prosthetic	needs,	and	the	thickness	and	
integrity	of	the	remaining	alveolar	bone	and	the	soft	tissues	(bone	
and	soft	tissue	phenotype).	Accumulated	evidence	from	a	growing	
number	of	randomized	clinical	trials	has	contributed	to	sharpen	the	
assessment.
The	following	general	consideratons/recommendations	can	help	
in	assisting	the	decision-	making	process:
•	 The	presence	of	an	acute	 local	 infection	may	 render	unpredict-
able	 outcomes	 following	 immediate	 implant	 placement	 or	 alve-
olar	 ridge	 preservation/ridge	 augmentation	 (ARP/RA).	 In	 such	
situations,	 early,	 delayed	 or	 late	 implant	 placement	 should	 be	
considered.
•	 The	absence	of	primary	stability	upon	implant	placement	and/or	
inability	to	place	the	implant	in	a	favourable,	restoratively	driven	
position	 speaks	 against	 the	 indication	 of	 implant	 placement.	 In	
such	 situations,	ARP/RA	and	delayed	or	 late	 implant	placement	
with	simultaneous	or	staged	alveolar	ridge	augmentation	(implant	
site	development)	should	be	considered.
•	 A	 damaged	 alveolus,	 particularly	 in	 the	 presence	 of	 large	 buc-
cal	dehiscence	or	coronal	 fenestration,	 should	be	 recognized	as	
a	 clinical	 scenario	 in	which	 the	 indication	of	 immediate	 implant	
placement	may	be	associated	with	a	higher	risk	of	achieving	un-
favourable	 therapeutic	 outcomes.	 In	 such	 situations,	 clinicians	
should	consider	an	early	implant	placement	protocol	or	ridge	re-
construction	at	the	time	of	tooth	extraction	and	delayed	or	late	
implant	placement.
•	 The	presence	of	an	 intact	alveolus	and	a	thick	periodontal	phe-
notype	 represents	 a	 favourable	 scenario	 to	 indicate	 immediate	
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implant	placement,	particularly	so	in	subjects	with	low	aesthetic	
demands	and/or	in	non-aesthetic	areas.
•	 The	presence	of	a	thin	periodontal	phenotype	and/or	a	high	smile	
line	in	subjects	with	high	aesthetic	demands	represents	an	unfa-
vourable	scenario	for	the	indication	of	immediate	or	early	implant	
placement.	In	such	situations,	ARP-SG	and	delayed	or	late	implant	
placement	should	be	considered.	Consideration	of	the	need	and	
role	 of	 soft	 tissue	 augmentation	 in	 such	 cases	was	 beyond	 the	
scope	of	this	specific	consensus.
•	 In	subjects	presenting	uncontrolled	local	and/or	systemic	condi-
tions	 that	may	alter	 the	healing	dynamics	of	extraction	 sockets	
(e.g.	smoking,	diabetes	mellitus	and	severe	autoimmune	diseases),	
the	 indication	 of	 delayed	 or	 late	 implant	 placement	 should	 be	
considered	over	immediate	or	early	implant	placement.	Clinicians	
must	be	aware	that	the	outcomes	of	ARP/RA	procedures	may	be	
negatively	affected	by	the	presence	of	such	systemic	conditions	
regardless	of	the	timing	of	implant	placement.
6.2 | Recommendations for future research
The	group	felt	that,	while	considerable	progress	has	been	made	since	
the	last	time	the	Workshop	addressed	the	quality	of	research	in	im-
plant	dentistry	(Tonetti	&	Palmer,	2012),	several	challenges	persist.
Future	 research	shall	 focus	on	providing	appropriate	compara-
tive	data	assessing	the	efficacy,	cost-	effectiveness	and	patient	ac-
ceptability	of	different	approaches.	Such	studies	shall	be	designed	in	
order	to	enable	the	development	of	evidence-	based	decision-	making	
algorithms	and	clinical	recommendations.	Emphasis	on	methodologi-
cal	issues	in	design,	execution	and	reporting	is	required	to	continue	
to	improve	control	of	bias,	external	validity	and	integrity	of	research	
findings.
In	order	to	sustain	decisive	improvements	in	the	evidence	base,	
the	 research	 community	 should	 focus	 on	 definition	 of	 a	 standard	
outcome	data	 set,	 on	 clinically	meaningful	 outcomes	 and	on	 clini-
cally	relevant	differences	to	appropriately	power	studies.
Greater	emphasis	on	the	evaluation	and	report	of	harm,	adverse	
events	and	PROMs	in	all	clinical	studies	is	urgently	required.
Given	 the	 perception	 that	 different	 procedures	 have	 dissimilar	
indications	based	on	specific	clinical	situations,	definition	of	a	single	
standard	 of	 care	 to	 be	 used	 as	 the	 control	 group	 for	 comparative	
studies	is	problematic.	Randomized	controlled	clinical	trials	will	have	
to	use	different	control	groups	based	on	the	clinical	situation	being	
studied.
Valuable	insight	is	to	be	gained	from	analytical	studies	aimed	at	
assessing	the	significance	of	different	prognostic	factors,	including	
the	reason	for	tooth	loss/extraction	and/or	the	phenotypic	charac-
teristics	of	the	residual	alveolus.	These	studies	will	have	to	be	high	
quality	and	provide	adequate	external	validity.
In	general,	 the	evidence	base	 in	 this	 field	primarily	emanates	
from	 single	 tooth	 replacement	 scenarios,	 and	 this	 has	 a	 pro-
found	 impact	 on	 the	 applicability	 of	 the	 available	 data	 to	multi-
ple	extractions	and/or	transitioning	from	a	natural	dentition	to	an	
implant-	retained	prosthesis.	While	 it	 is	 recognized	 that	 research	
on	multiple	extraction	sites	poses	additional	methodological	and	
analytical	challenges,	it	is	important	to	expand	the	evidence	base	
in	this	direction.
The	 population	 requiring	 tooth	 replacement	 is	 ageing	 and	
typically	 presents	with	 a	 considerable	 set	 of	 relevant	medical	 co-	
morbidities	and	the	long-	term	consumption	of	multiple	medications.	
Ethically	appropriate	research	on	tooth	replacement	in	special	needs	
groups	is	urgently	needed,	as	well.
CONFLIC T OF INTERE S T
Workshop	participants	filed	detailed	disclosure	of	potential	conflict	of	
interest	relevant	to	the	workshop	topics,	and	these	are	kept	on	file.	
Declared	 potential	 dual	 commitments	 included	 having	 received	 re-
search	funding,	consultant	fees	and	speaker	fee	from	Biomet	Zimmer,	
BioHorizons,	 Colgate,	 Dentaid,	 Dentsply	 Implants,	 Dentium,	 Geass,	
Geistlich	Pharma	AG,	Klockner,	MIS	Implants,	Osteogenics	Biomedical,	
Osteology	 Foundation,	 Procter	 &	 Gamble,	 Straumann,	 Sweden	 &	
Martina,	Sunstar	SA	and	VITA	Zahnfabrik.
ORCID
Maurizio S. Tonetti  https://orcid.org/0000-0002-2743-0137 
Gustavo Avila-Ortiz  https://orcid.org/0000-0002-5763-0201 
Jan Cosyn  https://orcid.org/0000-0001-5042-2875 
Filippo Graziani  https://orcid.org/0000-0001-8780-7306 
Phoebus Madianos  https://orcid.org/0000-0002-5990-5723 
Ignacio Sanz-Martin  https://orcid.org/0000-0001-7037-1163 
Daniel Thoma  https://orcid.org/0000-0002-1764-7447 
Fabio Vignoletti  https://orcid.org/0000-0002-4574-3671 
R E FE R E N C E S
Avila-Ortiz,	G.,	Chambrone,	L.,	&	Vignoletti,	F.	(2019).	Effect	of	alveolar	
ridge	preservation	 interventions	 following	 tooth	extraction:	A	 sys-
tematic	review	and	meta-	analysis.	Journal of Clinical Periodontology,	
46(Suppl	21),	195–223.
Cosyn,	 J.,	 Lat,	 L.,	 Seyssens,	 L.,	 Doornewaard,	 R.,	 Deschepper,	 E.,	 &	
Vervaeke,	S.	 (2019).	The	effectiveness	of	 immediate	 implant	place-
ment	 for	 single	 tooth	 replacement	 compared	 to	 delayed	 implant	
placement:	A	systematic	review	and	meta-	analysis.	Journal of Clinical 
Periodontology,	2019;	46(Suppl	21),	224–241.
Donos,	N.,	Dereka,	X.,	&	Calciolari,	E.	(2019).	The	use	of	bioactive	factors	
to	enhance	bone	regeneration.	A	narrative	review.	Journal of Clinical 
Periodontology,	46(Suppl	21),	124–161.
Gallucci,	 G.	 O.,	 Hamilton,	 A.,	 Zhou,	W.,	 Buser,	 D.,	 &	 Chen,	 S.	 (2018).	
Implant	placement	and	loading	protocols	in	partially	edentulous	pa-
tients:	A	systematic	review.	Clinical Oral Implants Research,	29(Suppl 
16),	106–134.
Graziani,	F.,	Chappuis,	V.,	Molina,	A.,	Lazarin,	R.,	Schmid,	E.,	Chen,	S.,	&	
Salvi,	G.	E.	(2019).	Effectiveness	and	clinical	performance	of	early	im-
plant	placement	for	the	replacement	of	single	teeth	in	anterior	areas:	
A	systematic	review.	Journal of Clinical Periodontology,	46(Suppl	21),	
242–256.
194  |     TONETTI ET al.
Guyatt,	 G.,	 Oxman,	 A.	 D.,	 Akl,	 E.	 A.,	 Kunz,	 R.,	 Vist,	 G.,	 Brozek,	 J.,	 …	
Schunemann,	 H.	 J.	 (2011).	 GRADE	 guidelines:	 1.	 Introduction-	
GRADE	evidence	profiles	and	summary	of	findings	tables.	Journal of 
Clinical Epidemiology,	64,	383–394.
Haugen,	H.	J.,	Lyngstadaas,	S.	P.,	Rossi,	F.,	&	Perale,	G.	(2019).	Bone	grafts:	
Which	 is	 the	 ideal	 biomaterial?	 Journal of Clinical Periodontology,	
46(Suppl	21),	92–102.
Kassebaum,	N.	 J.,	 Bernabe,	 E.,	Dahiya,	M.,	Bhandari,	 B.,	Murray,	C.	 J.,	
&	Marcenes,	W.	 (2014).	Global	burden	of	severe	tooth	 loss:	A	sys-
tematic	 review	 and	 meta-	analysis.	 Journal of Dental Research,	 93,	
20s–28s.
Omar,	O.,	Elgali,	I.,	Dahlin,	C.,	&	Thomsen,	P.	(2019).	Barrier	membranes:	
More	 than	 the	 barrier	 effect?	 Journal of Clinical Periodontology,	
46(Suppl	21),	103–123.
Sculean,	A.,	Stavropoulos,	A.,	&	Bosshardt,	D.	D.	(2019).	Self-regenerative	
capacity	of	intra-oral	bone	defects.	Journal of Clinical Periodontology,	
46(Suppl. 21):70–81.
Thoma,	D.	S.,	Bienz,	S.	P.,	Figuero,	E.,	Jung,	R.	E.,	&	Sanz-Martin,	I.	(2019).	
Efficacy	 of	 lateral	 bone	 augmentation	 performed	 simultaneously	
with	 dental	 implant	 placement.	 A	 systematic	 review	 and	 meta-	
analysis. Journal of Clinical Periodontology,	46(Suppl	21),	257–276.
Tonetti,	M.	S.,Jepsen,	S.,	&	Working	Group	2	of	the	European	Workshop	
On	 Periodontology.	 (2014).	 Clinical	 efficacy	 of	 periodontal	
plastic	 surgery	 procedures:	 Consensus	 report	 of	 Group	 2	 of	 the	
10th	 European	 Workshop	 on	 Periodontology.	 Journal of Clinical 
Periodontology,	41(Suppl	15),	S36–S43.
Tonetti,	M.,	&	Palmer,	R.	 (2012).	Clinical	 research	 in	 implant	dentistry:	
Study	 design,	 reporting	 and	 outcome	 measurements:	 Consensus	
report	 of	 Working	 Group	 2	 of	 the	 VIII	 European	 Workshop	 on	
Periodontology.	 Journal of Clinical Periodontology,	 39(Suppl	 12),	
73–80.
van	der	Weijden,	F.,	Dell'Acqua,	F.,	&	Slot,	D.	E.	 (2009).	Alveolar	bone	
dimensional	 changes	 of	 post-	extraction	 sockets	 in	 humans:	 A	 sys-
tematic	review.	Journal of Clinical Periodontology,	36,	1048–1058.
How to cite this article:	Tonetti	MS,	Jung	RE,	Avila-Ortiz	G,	
et	al.	Management	of	the	extraction	socket	and	timing	of	
implant	placement:	Consensus	report	and	clinical	
recommendations	of	group	3	of	the	XV	European	Workshop	
in	Periodontology.	J Clin Periodontol. 2019;46(Suppl. 21):183–
194. https	://doi.org/10.1111/jcpe.13131	
